Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 2
2017 1
2018 4
2019 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Kanner AM, et al. Among authors: burakgazi dalkilic e. Neurology. 2018 Jul 10;91(2):74-81. doi: 10.1212/WNL.0000000000005755. Epub 2018 Jun 13. Neurology. 2018. PMID: 29898971
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Kanner AM, et al. Among authors: burakgazi dalkilic e. Neurology. 2018 Jul 10;91(2):82-90. doi: 10.1212/WNL.0000000000005756. Epub 2018 Jun 13. Neurology. 2018. PMID: 29898974
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Park EL, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Kanner AM, et al. Among authors: burakgazi dalkilic e. Epilepsy Curr. 2018 Jul-Aug;18(4):269-278. doi: 10.5698/1535-7597.18.4.269. Epilepsy Curr. 2018. PMID: 30254528 Free PMC article.
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Park EL, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Kanner AM, et al. Among authors: burakgazi dalkilic e. Epilepsy Curr. 2018 Jul-Aug;18(4):260-268. doi: 10.5698/1535-7597.18.4.260. Epilepsy Curr. 2018. PMID: 30254527 Free PMC article.
Effect of sleep patterns on levetiracetam induced mood changes.
Taneja R, Hunter K, Burakgazi-Dalkilic E, Carran M. Taneja R, et al. Among authors: burakgazi dalkilic e. Epilepsy Behav. 2017 Oct;75:237-240. doi: 10.1016/j.yebeh.2017.07.038. Epub 2017 Aug 18. Epilepsy Behav. 2017. PMID: 28827040
A case of levetiracetam induced bullous pemphigoid.
Karadag AS, Bilgili SG, Calka O, Onder S, Kosem M, Burakgazi-Dalkilic E. Karadag AS, et al. Among authors: burakgazi dalkilic e. Cutan Ocul Toxicol. 2013 Jun;32(2):176-8. doi: 10.3109/15569527.2012.725444. Epub 2012 Oct 3. Cutan Ocul Toxicol. 2013. PMID: 23030621
Effects of antiepileptic drugs on hormones.
Burakgazi Dalkilic E. Burakgazi Dalkilic E. Neurosci Lett. 2021 May 29;754:135800. doi: 10.1016/j.neulet.2021.135800. Epub 2021 Mar 8. Neurosci Lett. 2021. PMID: 33705937 No abstract available.